Immune factors and immunoregulation in tuberculosis

Abstract

Pathogens causing tuberculosis and other chronic infectious diseases of major public health importance commonly have complex mechanisms involved in their persistence in the host despite specific and sometimes strong immune responses. These diseases are also associated with the lack of efficient vaccines, difficult therapeutics and a high mortality rate among susceptible individuals. Here, we will review features of the host immune response that contribute to the occurrence of disease. In addition, we propose that the immune responses observed in tuberculosis cannot be interpreted solely on the basis of a Th1-Th2 counter-regulatory paradigm since there is growing evidence that natural regulatory T cells may play an important role in the regulation of host immune responses against Mycobacterium tuberculosis. Thus, the development of more effective vaccines against this bacterial disease should take into account the role of natural regulatory T cells in the progression to severe disease and persistence of infection. Finally, new treatments based on manipulation of regulatory T cells should be investigated.

Do leprosy and tuberculosis generate a systemic inflammatory shift? Setting the ground for a new dialogue between experimental immunology and bioarchaeology

“…In the end, a constant battle will unfold between the host and the pathogen wherein the outcome depends on multiple factors. In cases of latent or dormant TB, most patients mount a strong immune response, containing but not eliminating the infection (Ferraz et al, 2006;Flynn and Chan, 2001).…”

Cytokine Gene Polymorphisms across Tuberculosis Clinical Spectrum in Pakistani Patients

“…Identification of these high-risk individuals in recently exposed/ infected individuals is of great importance to TB Control Programs for reducing the disease burden in the community. Association of pathological severity with increased circulating levels of different pro-inflammatory and or down-regulatory cytokines in tuberculosis is fairly well established [6]. An increasing number of studies have shown that single nucleotide polymorphisms (SNPs) located in the promoter or coding regions of cytokine genes result in differential cytokine secretion due to altered transcriptional activation.…”

Tuberculosis’ epidemiology in Brazil in the last 10 years / Epidemiologia da tuberculose no Brasil nos últimos 10 anos / Epidemiología de la tuberculosis en Brasil en los últimos 10 años

“…Os sinais e sintomas clínicos refletem o sítio da infecção com a doença primária usualmente restrita ao trato respiratório inferior, a doença é insidiosa no início de seu desenvolvimento. Os portadores não apresentam queixas não específicas como mal estar, perda de peso, tosse e sudorese noturna, e ainda a expectoração pode ser escassa, sanguinolenta ou purulenta, onde a produção do escarro com hemoptise revela a destruição do tecido (1) .…”